Expression of targeted ribozyme against telomerase RNA causes altered expression of several other genes in tumor cells

Tumor Biology

Volumn 35, Issue 6, 2014, Pages 5539-5550

  Ramakrishnan, Suresh Kumar ^a,b   Varshney, Akhil ^a   Sharma, Amod ^a   Das, Bhudev C ^b,c   Yadava, Pramod K ^a  

^a JAWAHARLAL NEHRU UNIVERSITY   (India)

^b Institute of Cytology and Preventive Oncology ICMR   (India)

^c UNIVERSITY OF DELHI   (India)

Author keywords

Differential display; Targeted ribozyme; Telomerase RNA; Telomerase associated genes

Indexed keywords

PROTEOME; RIBOZYME; RNA; TELOMERASE;

APOPTOSIS; ARTICLE; BIOGENESIS; CELL CYCLE REGULATION; CELL STRUCTURE; CHROMATIN; CONTROLLED STUDY; GENE EXPRESSION; HELA CELL LINE; MOLECULAR CLONING; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RIBOSOME; TELOMERE HOMEOSTASIS; TELOMERE SHORTENING; TUMOR CELL; TWO DIMENSIONAL GEL ELECTROPHORESIS; WILD TYPE;

APOPTOSIS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HELA CELLS; HUMANS; NEOPLASMS; PROTEOME; RETINOBLASTOMA-BINDING PROTEIN 2; RNA; RNA, CATALYTIC; TELOMERASE;

EID: 84904759623     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-014-1729-z     Document Type: Article

References (59)

1. Shay JW, Bacchetti S. A survey of telomerase activity in human cancer. Eur J Cancer. 1997;33(5):787-91.
2. Avilion AA, Piatyszek MA, Gupta J, Shay JW, Bacchetti S, Greider CW. Human telomerase RNA and telomerase activity in immortal cell lines and tumor tissues. Cancer Res. 1996;56(3):645-50. (Pubitemid 26043667)
3. Smith LL, Coller HA, Roberts JM. Telomerase modulates expression of growth-controlling genes and enhances cell proliferation. Nat Cell Biol. 2003;5(5):474-9. (Pubitemid 36592272)
4. Li S, Crothers J, Haqq CM, Blackburn EH. Cellular and gene expression responses involved in the rapid growth inhibition of human cancer cells by RNA interference-mediated depletion of telomerase RNA. J Biol Chem. 2005;280(25):23709-17. (Pubitemid 40884853)
5. Bagheri S, Nosrati M, Li S, Fong S, Torabian S, Rangel J, et al.Genes and pathways downstream of telomerase in melanoma metastasis. Proc Natl Acad Sci U S A. 2006;103(30):11306-11. (Pubitemid 44156513)
6. Beliveau A, Bassett E, Lo AT, Garbe J, Rubio MA, Bissell MJ, et al. p53-dependent integration of telomere and growth factor deprivation signals. Proc Natl Acad Sci U S A. 2007;104(11):4431-6. (Pubitemid 47186243)
7. Stewart SA, Hahn WC, O'Connor BF, Banner EN, Lundberg AS, Modha P, et al. Telomerase contributes to tumorigenesis by a telomere length-independent mechanism. Proc Natl Acad Sci U S A. 2002;99(20):12606-11.
8. Chang S, DePinho RA. Telomerase extracurricular activities. Proc Natl Acad Sci U S A. 2002;99(20):12520-2.
9. Zhu H, Fu W, Mattson MP. The catalytic subunit of telomerase protects neurons against amyloid beta-peptide-induced apoptosis. J Neurochem. 2000;75(1):117-24. (Pubitemid 30418176)
10. Broccoli D, Godley LA, Donehower LA, Varmus HE, de Lange T. Telomerase activation in mouse mammary tumors: lack of detectable telomere shortening and evidence for regulation of telomerase RNA with cell proliferation. Mol Cel Biol. 1996;16(7):3765-72. (Pubitemid 26199896)
11. Greenberg RA, Chin L, Femino A, Lee KH, Gottlieb GJ, Singer RH, et al. Short dysfunctional telomeres impair tumorigenesis in the INK4a(delta2/3) cancer-prone mouse. Cell. 1999;97(4):515-25. (Pubitemid 29231174)
12. Gonzalez-Suarez E, Samper E, Ramirez A, Flores JM, Martin- Caballero J, Jorcano JL, et al. Increased epidermal tumors and increased skin wound healing in transgenic mice overexpressing the catalytic subunit of telomerase, mTERT, in basal keratinocytes. EMBO J. 2001;20(11):2619-30. (Pubitemid 32938547)
13. Martinez P, Blasco MA. Telomeric and extra-telomeric roles for telomerase and the telomere-binding proteins. Nat Rev Cancer. 2011;11(3):161-76.
14. Yokoyama Y, Takahashi Y, Shinohara A, Lian Z, Wan X, Niwa K, et al. Attenuation of telomerase activity by a hammerhead ribozyme targeting the template region of telomerase RNA in endometrial carcinoma cells. Cancer Res. 1998;58(23):5406-10. (Pubitemid 28551123)
15. Zhang X, Mar V, Zhou W, Harrington L, Robinson MO. Telomere shortening and apoptosis in telomerase-inhibited human tumor cells. Genes Dev. 1999;13(18):2388-99. (Pubitemid 29453610)
16. Vaish NK, Kore AR, Eckstein F. Recent developments in the hammerhead ribozyme field. Nucleic Acids Res. 1998;26(23):5237-42. (Pubitemid 28542719)
17. Shay JW, Wright WE. Telomerase: a target for cancer therapeutics. Cancer cell. 2002;2(4):257-65. (Pubitemid 41043959)
18. Yatabe N, Kyo S, Kondo S, Kanaya T, Wang Z, Maida Y, et al. 2-5A antisense therapy directed against human telomerase RNA inhibits telomerase activity and induces apoptosis without telomere impairment in cervical cancer cells. Cancer Gene Ther. 2002;9(7):624-30. (Pubitemid 34734427)
19. Zhu Y, Tomlinson RL, Lukowiak AA, Terns RM, Terns MP. Telomerase RNA accumulates in Cajal bodies in human cancer cells. Mol Biol Cell. 2004;15(1):81-90. (Pubitemid 38044945)
20. Chen JL, Greider CW. Functional analysis of the pseudoknot structure in human telomerase RNA. Proc Natl Acad Sci U S A. 2005;102(23):8080-5. discussion 77-9.
21. Liang P, Pardee AB. Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. Science. 1992;257(5072):967-71.
22. Liang P, Zhu W, Zhang X, Guo Z, O'Connell RP, Averboukh L, et al. Differential display using one-base anchored oligo-dT primers. Nucleic Acids Res. 1994;22(25):5763-4.
23. Wright WE, Brasiskyte D, Piatyszek MA, Shay JW. Experimental elongation of telomeres extends the lifespan of immortal x normal cell hybrids. EMBO J. 1996;15(7):1734-41. (Pubitemid 26112834)
24. Cayuela ML, Flores JM, Blasco MA. The telomerase RNA component Terc is required for the tumour-promoting effects of Tert overexpression. EMBO Rep. 2005;6(3):268-74. (Pubitemid 40485624)
25. Jensen LJ, Kuhn M, Stark M, Chaffron S, Creevey C, Muller J, et al. STRING 8-a global view on proteins and their functional interactions in 630 organisms. Nucleic Acids Res. 2009;37(Database issue):D412-6.
26. Ouellette MM, Liao M, Herbert BS, Johnson M, Holt SE, Liss HS, et al. Subsenescent telomere lengths in fibroblasts immortalized by limiting amounts of telomerase. J Biol Chem. 2000;275(14):10072-6. (Pubitemid 30202057)
27. Kondo S, Tanaka Y, Kondo Y, Hitomi M, Barnett GH, Ishizaka Y, et al. Antisense telomerase treatment: induction of two distinct pathways, apoptosis and differentiation. FASEB J: Off Publ Fed Am Soc Exp Biol. 1998;12(10):801-11. (Pubitemid 28294670)
28. Feng J, Funk WD, Wang SS, Weinrich SL, Avilion AA, Chiu CP, et al. The RNA component of human telomerase. Science. 1995;269(5228):1236-41.
29. Scheffner M, Werness BA, Huibregtse JM, Levine AJ, Howley PM. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell. 1990;63(6):1129-36. (Pubitemid 120035062)
30. Boyer SN, Wazer DE, Band V. E7 protein of human papilloma virus- 16 induces degradation of retinoblastoma protein through the ubiquitin-proteasome pathway. Cancer Res. 1996;56(20):4620-4. (Pubitemid 26338060)
31. Einarson MB, Cukierman E, Compton DA, Golemis EA. Human enhancer of invasion-cluster, a coiled-coil protein required for passage through mitosis. Mol Cell Biol. 2004;24(9):3957-71. (Pubitemid 38496173)
32. Montanaro L, Mazzini G, Barbieri S, Vici M, Nardi-Pantoli A, Govoni M, et al. Different effects of ribosome biogenesis inhibition on cell proliferation in retinoblastoma protein- and p53-deficient and proficient human osteosarcoma cell lines. Cell Prolif. 2007;40(4):532-49. (Pubitemid 47063287)
33. Pool MR, Stumm J, Fulga TA, Sinning I, Dobberstein B. Distinct modes of signal recognition particle interaction with the ribosome. Science. 2002;297(5585):1345-8. (Pubitemid 34913172)
34. Amalric F, Bachellerie JP, Caboche M. RNA methylation and control of eukaryotic RNA biosynthesis: processing and utilization of undermethylated tRNAs in CHO cells. Nucleic Acids Res. 1977;4(12):4357-70. (Pubitemid 8311869)
35. Chiang PK, Gordon RK, Tal J, Zeng GC, Doctor BP, Pardhasaradhi K, et al. S-adenosylmethionine and methylation. FASEB J: Off Publ Fed Am Soc Exp Biol. 1996;10(4):471-80. (Pubitemid 26120322)
36. Thomas DM, Yang HS, Alexander K, Hinds PW. Role of the retinoblastoma protein in differentiation and senescence. Cancer Biol Ther. 2003;2(2):124-30.
37. Benevolenskaya EV. Histone H3K4 demethylases are essential in development and differentiation. Biochim et Biol Cell. 2007;85(4):435-43. (Pubitemid 47518039)
38. Benevolenskaya EV, Murray HL, Branton P, Young RA, Kaelin Jr WG. Binding of pRB to the PHD protein RBP2 promotes cellular differentiation. Mol Cell. 2005;18(6):623-35. (Pubitemid 40804799)
39. Gutierrez GM, Kong E, Hinds PW. Master or slave: the complex relationship of RBP2 and pRb. Cancer Cell. 2005;7(6):501-2. (Pubitemid 40799242)
40. Christensen J, Agger K, Cloos PA, Pasini D, Rose S, Sennels L, et al. RBP2 belongs to a family of demethylases, specific for triand dimethylated lysine 4 on histone 3. Cell. 2007;128(6):1063-76. (Pubitemid 46427869)
41. Masutomi K, Possemato R, Wong JM, Currier JL, Tothova Z, Manola JB, et al. The telomerase reverse transcriptase regulates chromatin state and DNA damage responses. Proc Natl Acad Sci U S A. 2005;102(23):8222-7. (Pubitemid 40800070)
42. Moebius FF, Fitzky BU, Wietzorrek G, Haidekker A, Eder A, Glossmann H. Cloning of an emopamil-binding protein (EBP)-like protein that lacks sterol delta8-delta7 isomerase activity. Biochem J. 2003;374(Pt 1):229-37. (Pubitemid 37046947)
43. O' Shaughnessy RF, Welti JC, Cooke JC, Avilion AA, Monks B, Birnbaum MJ, et al. AKT-dependent HspB1 (Hsp27) activity in epidermal differentiation. J Biol Chem. 2007;282(23):17297-305. (Pubitemid 47093238)
44. Paramio JM, Segrelles C, Ruiz S, Jorcano JL. Inhibition of protein kinase B (PKB) and PKCzeta mediates keratin K10-induced cell cycle arrest. Mol Cell Biol. 2001;21(21):7449-59. (Pubitemid 32953495)
45. Reichelt J, Furstenberger G, Magin TM. Loss of keratin 10 leads to mitogen-activated protein kinase (MAPK) activation, increased keratinocyte turnover, and decreased tumor formation in mice. J Investig Dermatol. 2004;123(5):973-81. (Pubitemid 39391945)
46. Kedde M, le Sage C, Duursma A, Zlotorynski E, van Leeuwen B, Nijkamp W, et al. Telomerase-independent regulation of ATR by human telomerase RNA. J Biol Chem. 2006;281(52):40503-14. (Pubitemid 46043302)
47. Ball HL, Cortez D. ATRIP oligomerization is required for ATRdependent checkpoint signaling. J Biol Chem. 2005;280(36):31390-6. (Pubitemid 41291879)
48. Gallegos JR, Litersky J, Lee H, Sun Y, Nakayama K, Nakayama K, et al. SCF TrCP1 activates and ubiquitylates TAp63gamma. J Biol Chem. 2008;283(1):66-75.
49. Ray D, Terao Y, Nimbalkar D, Chu LH, Donzelli M, Tsutsui T, et al. Transforming growth factor beta facilitates beta-TrCP-mediated degradation of Cdc25A in a Smad3-dependent manner. Mol Cell Biol. 2005;25(8):3338-47. (Pubitemid 40464333)
50. Ougolkov A, Zhang B, Yamashita K, Bilim V, Mai M, Fuchs SY, et al. Associations among beta-TrCP, an E3 ubiquitin ligase receptor, beta-catenin, and NF-kappaB in colorectal cancer. J Natl Cancer Inst. 2004;96(15):1161-70. (Pubitemid 39207052)
51. Truong AB, Kretz M, Ridky TW, Kimmel R, Khavari PA. p63 regulates proliferation and differentiation of developmentally mature keratinocytes. Genes Dev. 2006;20(22):3185-97. (Pubitemid 44790632)
52. Cosme-Blanco W, Shen MF, Lazar AJ, Pathak S, Lozano G, Multani AS, et al. Telomere dysfunction suppresses spontaneous tumorigenesis in vivo by initiating p53-dependent cellular senescence. EMBO Rep. 2007;8(5):497-503. (Pubitemid 46696521)
53. Sharma GG, Gupta A, Wang H, Scherthan H, Dhar S, Gandhi V, et al. hTERT associates with human telomeres and enhances genomic stability and DNA repair. Oncogene. 2003;22(1):131-46. (Pubitemid 36152891)
54. Gorbunova V, Seluanov A, Pereira-Smith OM. Evidence that high telomerase activity may induce a senescent-like growth arrest in human fibroblasts. J Biol Chem. 2003;278(9):7692-8.
55. Chan SW, Blackburn EH. Telomerase and ATM/Tel1p protect telomeres from nonhomologous end joining. Mol Cell. 2003;11(5):1379-87. (Pubitemid 36645155)
56. Zhang P, Chan SL, Fu W, Mendoza M, Mattson MP. TERT suppresses apoptotis at a premitochondrial step by a mechanism requiring reverse transcriptase activity and 14-3-3 protein-binding ability. FASEB J: Off Publ Fed Am Soc Exp Biol. 2003;17(6):767-9.
57. Choi J, Southworth LK, Sarin KY, Venteicher AS, Ma W, Chang W, et al. TERT promotes epithelial proliferation through transcriptional control of a Myc- and Wnt-related developmental program. PLoS Genet. 2008;4(1):e10.
58. Park JI, Venteicher AS, Hong JY, Choi J, Jun S, Shkreli M, et al. Telomerase modulates Wnt signalling by association with target gene chromatin. Nature. 2009;460(7251):66-72.
59. Ting NS, Pohorelic B, Yu Y, Lees-Miller SP, Beattie TL. The human telomerase RNA component, hTR, activates the DNA-dependent protein kinase to phosphorylate heterogeneous nuclear ribonucleoprotein A1. Nucleic Acids Res. 2009;37(18):6105-15.